Post-acute delivery of α5-GABAA antagonist, S 44819, improves functional recovery in juvenile rats following stroke

被引:1
作者
Lebrun, Florent [1 ,2 ]
Violle, Nicolas [1 ]
Letourneur, Annelise [1 ]
Muller, Christophe [1 ]
Fischer, Nicolas [1 ]
Levilly, Anthony [3 ]
Orset, Cyrille [2 ,3 ]
Sors, Aurore [4 ]
Vivien, Denis [2 ,5 ]
机构
[1] STROK LLIANCE, ETAP Lab, 13 Rue Bois Champelle, F-54500 Vandoeuvre Les Nancy, France
[2] UNICAEN, Physiopathol & Imaging Neurol Disorders PhIND, Inst Blood & Brain Caen Normandie BB C, Normandie Univ,GIP Cyceron,INSERM,UMR S U1237, Caen, France
[3] Univ Caen Basse Normandie, Ctr Univ Ressources Biol Curb, ESRP European Stroke Res Platform, Caen, France
[4] Inst Rech Int Servier, Suresnes, France
[5] CHU Caen Normandie, Dept Clin Res, Caen, France
关键词
Animal model; Behavioural tests; GABA; Recovery; Stroke; FOCAL CEREBRAL-ISCHEMIA; ARTERY OCCLUSION; TONIC INHIBITION; INTRALUMINAL SUTURE; MATURATION; HYPERACTIVITY; REDUCTION; RECEPTORS; DEFICITS; S44819;
D O I
10.1016/j.expneurol.2021.113881
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Hypo-excitability was reported in the peri-infarct tissue following stroke, an effect counteracted by a blockage of alpha 5-GABAA receptors in adult rodents. Our present study aims to evaluate the effect of a selective alpha 5-GABAA receptor antagonist, S 44819, in stroke in juvenile animals. We have set up and characterized an original model of transient ischemic stroke in 28 day-old Sprague-Dawley rats (45-min occlusion of the middle cerebral artery by intraluminal suture). In this model, S 44819 (1, 3 and 10 mg/kg, b.i.d) was orally administered from day 3 to day 16 after stroke onset. Sensorimotor recovery was assessed on day 1, day 9 and day 16 after stroke onset. Results show that rats treated with S 44819 at the doses of 3 and 10 mg/kg displayed a significant improvement of the neurological deficits (neuroscore) on day 9 and day 16, when compared with animals treated with vehicle. Grip test data analysis reveals that rats treated with S 44819 at the dose of 3 mg/kg displayed a better recovery on day 9 and day 16. These results are in agreement with those previously observed in adult rats, demonstrating that targeting alpha 5-GABAA receptors improves neurological recovery after stroke in juvenile rats.
引用
收藏
页数:9
相关论文
共 42 条
[1]   Reducing GABAA-mediated inhibition improves forelimb motor function after focal cortical stroke in mice [J].
Alia, Claudia ;
Spalletti, Cristina ;
Lai, Stefano ;
Panarese, Alessandro ;
Micera, Silvestro ;
Caleo, Matteo .
SCIENTIFIC REPORTS, 2016, 6
[2]  
Aspey BS, 1998, NEUROPATH APPL NEURO, V24, P487
[3]   L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for α5-containing GABAA receptors [J].
Atack, John R. ;
Bayley, Peter J. ;
Seabrook, Guy R. ;
Wafford, Keith A. ;
McKernan, Ruth M. ;
Dawson, Gerard R. .
NEUROPHARMACOLOGY, 2006, 51 (06) :1023-1029
[4]   Assessing post-stroke behavior in mouse models of focal ischemia [J].
Balkaya, Mustafa ;
Kroeber, Jan M. ;
Rex, Andre ;
Endres, Matthias .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2013, 33 (03) :330-338
[5]   Middle cerebral artery occlusion in the rat by intraluminal suture - Neurological and pathological evaluation of an improved model [J].
Belayev, L ;
Alonso, OF ;
Busto, R ;
Zhao, WZ ;
Ginsberg, MD .
STROKE, 1996, 27 (09) :1616-1622
[6]   A secreted form of the β-amyloid precursor protein (sAPP695) improves spatial recognition memory in OF1 mice [J].
Bour, A ;
Little, S ;
Dodart, JC ;
Kelche, C ;
Mathis, C .
NEUROBIOLOGY OF LEARNING AND MEMORY, 2004, 81 (01) :27-38
[7]   Activation of endothelial ras-related C3 botulinum toxin substrate 1 (Rac1) improves post-stroke recovery and angiogenesis via activating Pak1 in mice [J].
Bu, Fan ;
Min, Jia-Wei ;
Munshi, Yashasvee ;
Lai, Yun-Ju ;
Qi, Li ;
Urayama, Akihiko ;
McCullough, Louise D. ;
Li, Jun .
EXPERIMENTAL NEUROLOGY, 2019, 322
[8]   Brain Excitability in Stroke The Yin and Yang of Stroke Progression [J].
Carmichael, S. Thomas .
ARCHIVES OF NEUROLOGY, 2012, 69 (02) :161-167
[9]   Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial [J].
Chabriat, Hugues ;
Bassetti, Claudio L. ;
Marx, Ute ;
Audoli-Inthavong, Marie-Laure ;
Sors, Aurore ;
Lambert, Estelle ;
Wattez, Marine ;
Hermann, Dirk M. .
LANCET NEUROLOGY, 2020, 19 (03) :226-233
[10]   Randomized Efficacy and Safety Trial with Oral S 44819 after Recent ischemic cerebral Event (RESTORE BRAIN study): a placebo controlled phase II study [J].
Chabriat, Hugues ;
Bassetti, Claudio L. ;
Marx, Ute ;
Picarel-Blanchot, Francoise ;
Sors, Aurore ;
Gruget, Celine ;
Saba, Barbara ;
Wattez, Marine ;
Audoli, Marie-Laure ;
Hermann, Dirk M. .
TRIALS, 2020, 21 (01)